Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Fragile X Syndrome
NCT03479476Phase 3Completed
- Sponsor
- University of California, Davis
- Start
- Apr 2018
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of metformin in Fragile X syndrome (FXS), sponsored by University of California, Davis. Started Apr 2018; status: completed.
02
Drugs
metformin
03
Conditions
Fragile X syndrome (FXS)
Beyond the preview
Go deeper on NCT03479476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03479476.